Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Hospice Financial Stress Associated with Recent CMS Changes Has Only One Solution, Says Delta Care Rx
  • USA - English


News provided by

Delta Care Rx

Feb 05, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Steubenville, Ohio (PRWEB) February 05, 2014 -- The Centers for Medicare & Medicaid Services (CMS) put forth its latest statements regarding their views on the issues that exist between the medication payment relationship that arises for Hospice patients that also have Medicare Part D coverage. Mentioned within statements by CMS was the following verbiage: “as a general rule, hospice providers are expected to cover virtually all drugs for hospice beneficiaries during the hospice election.”

We had to make a business decision to do as much as we could to separate our company from the phrases "PBM Spread" and "Med Per Diem," knowing that doing so would not only serve our clients,but it just might also end up changing an industry's perspective.

Post this

"Though I feel that CMS’s latest statements are contradictory to directives given by them in the past; preparing for the reality of the general rule likely becoming the norm over the course of 2014, should be an urgent call to action for all hospices nationwide to adopt better medication purchasing options that are TRULY transparent and pass-through from pharmacy benefit manager (PBMs) and/or local pharmacy providers," says Drew Mihalyo, Founder and President at Delta Care Rx.

He went on to say that "The monthly volume of medications covered by Hospice entities is going up as we speak. Brand name drug prices are always going to be difficult for the industry to afford, but there is great room for improvement on generic drug pricing traditionally given to Hospice clients by pharmacy providers or PBMs. For years now, the Hospice industry has accepted the fact, that in most cases, they are expected to pay for these products in one of two ways. The first is via overly expensive “per diem rates” that really limit overall availability to non-preferred medications NOT found on the provider’s preferred list (PDL), regardless of the relation of the drug to the hospice terminal diagnosis or other co-morbid diseases contributing to the less than 6 month prognosis. When Hospices do have to make a purchase for a drug not offered on the per diem provider’s PDL, they are often penalized financially by having to pay exorbitant rates or penalties. Thus, the continued use of a per diem medication purchasing model by the hospice makes it terribly hard for the hospice to comply with CMS’s latest statements. Other Hospices are funneled into buying each drug at a modest 25-50% discount off of the Average Wholesale Price (AWP) plus a dispensing fee. Though these discounts help, they are not enough and the hospice can never be completely sure if the numbers used to calculate the cost are authentic and honest. A majority of Pharmacy Benefit Managers out there are buying meds via their network pharmacy relationships at much deeper discounts than what they offer their Hospice clients. They are then making very large profits in serving clients by charging the Hospice one amount for a prescription, while then turning around and paying the pharmacist within their pharmacy network a MUCH lesser amount as dispensing reimbursement. What remains in the middle is a “PBM spread or PBM profit” for simply administering the electronic adjudication of the claim. This PBM spread and lack of Hospice industry separation from these archaic types of medication purchasing models are hands down the biggest barriers preventing the Hospice industry from affording medications they are now expected by CMS to be paying for."

He finished by emphasizing that Delta Care Rx has a medication billing model, called Hospice Taper©, which allows our clients to avoid the issues with ALL OF THE ABOVE and instead buy medications at prices that are a complete pass-through of the aggressive discounts we already have in place via an existing pharmacy network. Early on, we had to make a crucial business decision to do as much as we could to separate our company from phrases like "PBM Spread" and "Medication Per Diem," knowing that doing so would not only serve our clients well, but it just might also end up changing an industry's perspective.

The privately held, pharmacist owned and operated, hospice specific, nationwide pharmacy benefit management (PBM) company has built a rapidly expanding book of business by staying true to the core values that brought the company to life years ago. REAL business transparency, pass-through and fully auditable medication purchasing agreements, innovative technology unique to the company (like DEA and SureScripts Certified e-Prescribing of Controlled and Non-Controlled Meds), extreme customer service, and decades of hospice industry experience on the part of ownership, management, and staff has put the Ohio based company at the top of the list when it comes to competent and up-to-date Hospice Pharmacy Benefit Management services.

More information about the company’s readiness to support current and prospective Hospice clients is available at http://www.DeltaCareRx.com.

"It's not immoral nor unethical to think about the cost of therapy."

Andrew M, Delta Care Rx, http://www.DeltaCareRx.com, +1 (412) 539-9337, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.